CN Stock MarketDetailed Quotes

Harbin Gloria Pharmaceuticals (002437)

Watchlist
  • 3.25
  • -0.01-0.31%
Trading May 14 11:03 CST
7.25BMarket Cap17.57P/E (TTM)

Harbin Gloria Pharmaceuticals (002437) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
维生素类药物954.35M44.69%
Cardio-cerebrovascular drugs593.18M27.78%
Orthopedic drugs226.84M10.62%
Electrolyte drugs158.34M7.41%
Antitumor drugs75.15M3.52%
Antiinfective drugs44.58M2.09%
其他用药领域36.44M1.71%
糖尿病类药物32.13M1.50%
镇痛类药物10.06M0.47%
Other4.38M0.21%
View all

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
化药行业1.95B91.34%
Traditional Chinese medicine industry180.56M8.46%
Other industries4.38M0.21%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Domestic2.13B99.75%
Abroad5.31M0.25%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More